Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Parkinson's Disease

Free Subscription 08.12.2025 1 Exp Neurol 2 J Neural Transm (Vienna) 1 J Neurol Neurosurg Psychiatry 1 J Neurosci 4 Mov Disord 1 Nat Rev Neurol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Exp Neurol

1. SABOURIN S, Modi K, Williams J, Singh R, et al
   Levodopa differentially modulates spectral features in cerebellum and basal ganglia in a rodent model of Parkinson's disease.
   Exp Neurol. 2025;397:115579.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

2. PEREZ-SORIANO A, Painous C, Fernandez M, Perez-Montesino J, et al
   Neurofilament light chain as a diagnostic and prognostic biomarker in atypical parkinsonisms: current evidence, new data, challenges, and future directions.
   J Neural Transm (Vienna). 2025 Dec 4. doi: 10.1007/s00702-025-03070.
   PubMed         Abstract available
   
   
3. SCHRAG A, Lyall R, Arabi S, Sheehan G, et al
   Methods to detect anxiety in Parkinsons' disease.
   J Neural Transm (Vienna). 2025 Dec 4. doi: 10.1007/s00702-025-03068.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

4. HIGASHI A, Mizutani Y, Ohdake R, Maeda Y, et al
   Metabolic profiles associated with fat loss in Parkinson's disease.
   J Neurol Neurosurg Psychiatry. 2025 Nov 30:jnnp-2025-336929.
   PubMed         Abstract available
   
   

   
   J Neurosci

5. 
   Erratum: Spencer et al., "Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in alpha-Synuclein Models of Parkinson's and Lewy Body Diseases".
   J Neurosci. 2025 Dec 3:e2123252025. doi: 10.1523/JNEUROSCI.2123-25.2025.
   PubMed        
   
   

   
   Mov Disord

6. AL ALI J, McKay JL, Nocera JR, Isbaine F, et al
   Bilateral Deep Brain Stimulation of the Subthalamic Nucleus or Globus Pallidus Internus Improves Gait Impairment in Parkinson's Disease.
   Mov Disord. 2025 Dec 4. doi: 10.1002/mds.70146.
   PubMed         Abstract available
   
   
7. MARINESCU AM, Machado V, Pagano G, Muelhardt NM, et al
   Cerebrospinal Fluid Biomarkers of NLRP3 Pathway, Immune Dysregulation, and Neurodegeneration in Parkinson's Disease: A Meta-Analysis.
   Mov Disord. 2025 Nov 29. doi: 10.1002/mds.70103.
   PubMed         Abstract available
   
   
8. JAAKKOLA E, Koponen M, Kaasinen V, Hietala J, et al
   Bipolar Disorder as a Long-Term Risk Factor for Parkinson's Disease: A Nationwide Case-Control Study.
   Mov Disord. 2025 Nov 29. doi: 10.1002/mds.70135.
   PubMed         Abstract available
   
   
9. RASCOL O, Ory-Magne F, Meissner WG, Maltete D, et al
   Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK).
   Mov Disord. 2025 Nov 29. doi: 10.1002/mds.70120.
   PubMed         Abstract available
   
   

   
   Nat Rev Neurol

10. OIKONOMOU P, Akhoundi FH, Olfati N, Litvan I, et al
    Characteristics and mechanisms of cognitive impairment in Parkinson disease.
    Nat Rev Neurol. 2025 Dec 3. doi: 10.1038/s41582-025-01163.
    PubMed         Abstract available
    
    

    
    PLoS One

11. GUO L, Li Q, Li J, Yang F, et al
    ceRNA regulatory network and immune-neurodegenerative mechanisms of peripheral CD4+ T cells in parkinson's disease.
    PLoS One. 2025;20:e0337808.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.